{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:42:48Z","timestamp":1771231368055,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.eprac.2024.12.020","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T05:53:12Z","timestamp":1736056392000},"page":"426-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of Second Primary Malignancies in Patients With Well-Differentiated Neuroendocrine Tumors"],"prefix":"10.1016","volume":"31","author":[{"given":"Kosma","family":"Woli\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-0613","authenticated-orcid":false,"given":"Pawe\u0142","family":"Komarnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Musia\u0142kiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Gut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2024.12.020_bib1","doi-asserted-by":"crossref","DOI":"10.5603\/ep.98169","article-title":"Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine","volume":"74","author":"Bry\u015b","year":"2023","journal-title":"Endokrynol Pol"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.020_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5603\/EP.a2022.0049","article-title":"Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours)","volume":"73","author":"Kos-Kud\u0142a","year":"2022","journal-title":"Endokrynol Pol"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.020_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000443166","article-title":"ENETS consensus guidelines update for colorectal neuroendocrine neoplasms","volume":"103","author":"Ramage","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"12","key":"10.1016\/j.eprac.2024.12.020_bib4","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s00595-020-01988-7","article-title":"Neuroendocrine tumors of the lung: clinicopathological and molecular features","volume":"50","author":"Iyoda","year":"2020","journal-title":"Surg Today"},{"key":"10.1016\/j.eprac.2024.12.020_bib5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.5114\/aoms.2017.64979","article-title":"Hindgut neuroendocrine neoplasms \u2013 characteristics and prognosis","volume":"6","author":"Gut","year":"2017","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.020_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"12","key":"10.1016\/j.eprac.2024.12.020_bib7","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A\u00a0common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.eprac.2024.12.020_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.020_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5603\/EP.a2022.0052","article-title":"Neuroendocrine neoplasms of the small intestine and the appendix - update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours)","volume":"73","author":"Bednarczuk","year":"2022","journal-title":"Endokrynol Pol"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.020_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231991","article-title":"Early life exposures associated with risk of small intestinal neuroendocrine tumors","volume":"15","author":"VanDerslice","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.eprac.2024.12.020_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: a review of neuroendocrine tumors and carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.020_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2018-00160","article-title":"Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms","volume":"40","author":"Mafficini","year":"2019","journal-title":"Endocr Rev"},{"issue":"19","key":"10.1016\/j.eprac.2024.12.020_bib13","first-page":"5542","article-title":"Circulating neuroendocrine tumor biomarkers: past, present and future","volume":"11","author":"Komarnicki","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.020_bib14","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/jamaoncol.2021.4531","article-title":"Incidence and predictors of second primary cancers in patients with neuroendocrine tumors","volume":"7","author":"Bateni","year":"2021","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.020_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/1096-9098(200012)75:4<306::AID-JSO14>3.0.CO;2-3","article-title":"Gastrointestinal carcinoid tumors and second primary malignancies","volume":"75","author":"Habal","year":"2000","journal-title":"J\u00a0Surg Oncol"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.020_bib16","doi-asserted-by":"crossref","first-page":"e220337","DOI":"10.1530\/ERC-22-0337","article-title":"Second primary cancers and survival among neuroendocrine tumor patients","volume":"30","author":"Bateni","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.020_bib17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1159\/000530238","article-title":"Second primary malignancies in patients with a neuroendocrine neoplasm in england","volume":"113","author":"Russell","year":"2023","journal-title":"Neuroendocrinology"},{"issue":"1\u20132","key":"10.1016\/j.eprac.2024.12.020_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000381716","article-title":"Incidence of second primary malignancies in patients with neuroendocrine tumours","volume":"102","author":"Clift","year":"2015","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.020_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12020-013-9911-4","article-title":"Secondary malignancy in patients with sporadic neuroendocrine neoplasia","volume":"44","author":"Krausch","year":"2013","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.020_bib20","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1245\/s10434-014-3774-7","article-title":"Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors","volume":"21","author":"Kauffmann","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2 C","key":"10.1016\/j.eprac.2024.12.020_bib21","first-page":"1049","article-title":"Neuroendocrine tumors and second primary malignancy - a relationship with clinical impact?","volume":"24","author":"Prommegger","year":"2004","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.020_bib22","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.5301\/tj.5000598","article-title":"Second malignancy risk in patients with bronchopulmonary carcinoids: epidemiological results from Italian network of cancer registries","volume":"103","author":"Lococo","year":"2017","journal-title":"Tumori J"},{"issue":"10","key":"10.1016\/j.eprac.2024.12.020_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s12094-014-1174-x","article-title":"Second primary malignancies in patients with neuroendocrine tumors","volume":"16","author":"Reina","year":"2014","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"10.1016\/j.eprac.2024.12.020_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086414","article-title":"Second cancers in patients with neuroendocrine tumors","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.020_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10350-004-6119-y","article-title":"Risk of second cancers in patients with colorectal carcinoids","volume":"45","author":"Tichansky","year":"2002","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.020_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100613","article-title":"The risk of second primary malignancies in patients with lung neuroendocrine tumors: a population-based study on SEER database","volume":"44","author":"Bu","year":"2020","journal-title":"Curr Probl Cancer"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.020_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.92","article-title":"Co-occurrence of breast cancer and neuroendocrine tumours: new genetic insights beyond Multiple Endocrine Neoplasia syndromes","volume":"2","author":"Larouche","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.020_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1530\/ERC-11-0315","article-title":"Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas","volume":"19","author":"Kamp","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.eprac.2024.12.020_bib29","first-page":"11","article-title":"Clinical epigenetics of neuroendocrine tumors: the road ahead","volume":"15","author":"Colao","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eprac.2024.12.020_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.901435","article-title":"Epigenetic regulation in gastroenteropancreatic neuroendocrine tumors","volume":"12","author":"Crabtree","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.020_bib31","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/ERC-12-0338","article-title":"Neuroendocrine tumours: cracking the epigenetic code","volume":"20","author":"Karpathakis","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.020_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.020_bib33","doi-asserted-by":"crossref","first-page":"a026567","DOI":"10.1101\/cshperspect.a026567","article-title":"ATRX and DAXX: mechanisms and mutations","volume":"7","author":"Dyer","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.eprac.2024.12.020_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1047684","article-title":"Incidence of second primary malignancies in women with different stages of breast cancer","volume":"12","author":"Lin","year":"2023","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.020_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5603\/NJO.2023.0026","article-title":"Cancer incidence and mortality in Poland in 2020","volume":"73","author":"Wojciechowska","year":"2023","journal-title":"Nowotwory J Oncol"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.020_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40618-016-0565-y","article-title":"Risk of malignant neoplasms in acromegaly: a case\u2013control study","volume":"40","author":"Wolinski","year":"2017","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.eprac.2024.12.020_bib38","article-title":"Health-related complications of acromegaly\u2014risk of malignant neoplasms","volume":"30","author":"Ruchala","year":"2019","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.020_bib39","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-16-0178","article-title":"Management of endocrine disease: acromegaly and cancer: an old debate revisited","volume":"175","author":"Boguszewski","year":"2016","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:42:20Z","timestamp":1744717340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1530891X25000011"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.12.020","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Second Primary Malignancies in Patients With Well-Differentiated Neuroendocrine Tumors","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}